Forvis Mazars Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.9M Buy
56,691
+114
+0.2% +$26.6K 0.26% 47
2025
Q4
$11.7M Buy
56,577
+180
+0.3% +$35.6K 0.22% 51
2025
Q3
$10.5M Sell
56,397
-1,031
-2% -$177K 0.21% 58
2025
Q2
$8.77M Sell
57,428
-1,228
-2% -$189K 0.19% 62
2025
Q1
$9.73M Buy
58,656
+16,019
+38% +$2.51M 0.23% 52
2024
Q4
$6.17M Sell
42,637
-955
-2% -$148K 0.14% 80
2024
Q3
$7.06M Sell
43,592
-19,781
-31% -$3.15M 0.16% 77
2024
Q2
$9.26M Buy
63,373
+8,323
+15% +$1.24M 0.23% 60
2024
Q1
$8.71M Buy
55,050
+12,286
+29% +$1.96M 0.22% 65
2023
Q4
$6.7M Sell
42,764
-1,658
-4% -$254K 0.19% 70
2023
Q3
$6.92M Sell
44,422
-1,360
-3% -$224K 0.21% 68
2023
Q2
$7.58M Buy
45,782
+8,554
+23% +$1.38M 0.22% 73
2023
Q1
$5.77M Sell
37,228
-1,042
-3% -$168K 0.19% 76
2022
Q4
$6.76M Sell
38,270
-770
-2% -$133K 0.24% 66
2022
Q3
$6.38M Buy
39,040
+1,206
+3% +$204K 0.26% 61
2022
Q2
$6.71M Buy
37,834
+2,509
+7% +$447K 0.27% 59
2022
Q1
$6.26M Buy
35,325
+1,455
+4% +$248K 0.27% 46
2021
Q4
$5.79M Sell
33,870
-404
-1% -$66.1K 0.24% 48
2021
Q3
$5.54M Buy
34,274
+6,251
+22% +$1.07M 0.25% 45
2021
Q2
$4.62M Sell
28,023
-5,290
-16% -$876K 0.21% 49
2021
Q1
$5.47M Sell
33,313
-7,038
-17% -$1.14M 0.27% 41
2020
Q4
$6.35M Buy
40,351
+4,688
+13% +$692K 0.32% 37
2020
Q3
$5.31M Sell
35,663
-1,301
-4% -$193K 0.31% 44
2020
Q2
$5.2M Sell
36,964
-2,066
-5% -$301K 0.34% 39
2020
Q1
$5.12M Buy
39,030
+1,518
+4% +$215K 0.42% 29
2019
Q4
$5.47M Buy
37,512
+2,033
+6% +$276K 0.39% 34
2019
Q3
$4.59M Sell
35,479
-808
-2% -$106K 0.37% 35
2019
Q2
$5.05M Sell
36,287
-21,332
-37% -$2.95M 0.41% 29
2019
Q1
$8.05M Buy
57,619
+16,275
+39% +$2.18M 0.67% 20
2018
Q4
$5.33M Buy
41,344
+887
+2% +$124K 0.55% 24
2018
Q3
$5.59M Buy
40,457
+400
+1% +$53.2K 0.49% 24
2018
Q2
$4.86M Buy
40,057
+732
+2% +$91.3K 0.47% 25
2018
Q1
$5.04M Buy
39,325
+319
+0.8% +$43.1K 0.51% 24
2017
Q4
$5.45M Sell
39,006
-656
-2% -$91.4K 0.55% 21
2017
Q3
$5.16M Buy
39,662
+1,834
+5% +$243K 0.57% 19
2017
Q2
$5M Buy
37,828
+2,565
+7% +$327K 0.57% 21
2017
Q1
$4.39M Buy
35,263
+654
+2% +$78.1K 0.54% 21
2016
Q4
$3.99M Buy
34,609
+2,130
+7% +$246K 0.52% 24
2016
Q3
$3.84M Buy
32,479
+871
+3% +$106K 0.53% 23
2016
Q2
$3.83M Sell
31,608
-1,350
-4% -$153K 0.57% 26
2016
Q1
$3.57M Buy
32,958
+150
+0.5% +$15.5K 0.57% 26
2015
Q4
$3.37M Buy
32,808
+1,276
+4% +$128K 0.51% 28
2015
Q3
$2.94M Sell
31,532
-1,507
-5% -$146K 0.52% 22
2015
Q2
$3.22M Sell
33,039
-3,907
-11% -$391K 0.48% 27
2015
Q1
$3.72M Buy
36,946
+3,416
+10% +$347K 0.54% 24
2014
Q4
$3.51M Buy
33,530
+1,804
+6% +$190K 0.57% 26
2014
Q3
$3.38M Sell
31,726
-96
-0.3% -$9.96K 0.58% 21
2014
Q2
$3.33M Sell
31,822
-3,696
-10% -$374K 0.57% 21
2014
Q1
$3.49M Buy
35,518
+1,148
+3% +$106K 0.62% 23
2013
Q4
$3.15M Buy
34,370
+85
+0.2% +$7.83K 0.58% 25
2013
Q3
$2.97M Sell
34,285
-827
-2% -$74.2K 0.61% 26
2013
Q2
$3.02M Buy
+35,112
New +$2.98M 2.39% 6

Other funds holding JNJ

Forvis Mazars Wealth Advisors's JNJ Position: Q1 2026 in Review

Forvis Mazars Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 0.2% in Q1 2026, buying an estimated $26.6K and bringing the position to 56,691 shares worth $13.9M. The position accounts for 0.26% of the portfolio, ranked #47.

Forvis Mazars Wealth Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,627 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Forvis Mazars Wealth Advisors held 56,691 shares of Johnson & Johnson worth $13.9M as of Q1 2026.
  • Forvis Mazars Wealth Advisors bought 114 Johnson & Johnson shares in Q1 2026, an estimated $26.6K.
  • Johnson & Johnson made up 0.26% of Forvis Mazars Wealth Advisors's portfolio in Q1 2026, its #47 holding.
  • Forvis Mazars Wealth Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,627 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q1 2026, filed 1 May 2026.